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The nonobese diabetic (NOD)' mouse is a model ofhuman type I diabetes mel-
litus (1-4). The diabetic processes that occur in both species appear to reflect an
autoimmune response to the insulin-producing Q cells within the islets ofthe pan-
creas (5-7). Helper andcytotoxic T lymphocytes are found within the affected islets
in the NOD mouse (6, 8). We (9), and Bendelac et al. (10), have recently demon-
strated that both the CD4 and CD8 T cell subsets are necessary to transfer diabetes
in the NOD mouse. As in man, diabetes in the NOD mouse is controlled by mul-
tiple genetic loci, including one that islinked to, or islocated within, the MHC (11-13).
Although the stimulus for the induction of an autoimmune response in the NOD
mouse is still unknown, periductal and perivascular infiltrates and insulitis are ob-
served within the pancreas beginning at 3-5 wk of age (2, 3).
To determine whether the primary genetic defect that causes insulitis and dia-
betes in the NODmouse residesin the immunesystem or, alternatively, in the tissue
that is the target ofthe autoimmune response, we have initiated a series of studies
using irradiated (NOD x B10)F1 mice that have been reconstituted with NOD bone
marrow cells. (NOD x B10)F, mice do not develop diabetes or display insulitis (12).
In addition, since (NOD x B10)F, mice are semisyngeneic at the MHC with the
transferred NODbone marrowcells, an efficient immune responsecan bemounted
in the chimeras. In this study, we demonstrate that a majority ofirradiated (NOD
x B10)F, mice that receive NOD bone marrow cells develop insulitis and some be-
come diabetic. These NOD--, chimeras not only destroy their own a cells but also
reject the R cells present in transplanted pancreata obtained from newborn NOD
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and 1310 mice. These data indicate that the genetically determined insulitis and dia-
betes present in NOD mice are expressed at the level ofthe hematopoietic stem cells.
Materials and Methods
Animals.
￿
An NOD (Kd, I-A101 , Db) breeding nucleus was kindly provided by Dr. Yoshi-
hiro Tochino (Aburabi Laboratories, Shionogi and Co., Osaka,Japan) and C57B1/I0SnJ (B10)
(Kb, I-Ab, Db) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). (NOD
x BI0)F, mice were bred in our animal facility in Rahway, NJ. Mice used in this study were
housed under specific pathogen-free conditions.
Preparation and Analysis of Chimeras.
￿
Bone marrow cells were harvested from 5-7-wk-old
female donors. To remove mature T cells, bone marrow cells were incubated at 4°C for 30
min with a mixture of T cell-specific mAbs: antiThy-1 .2 (HO-13-4) (14) (TIB 99, American
Type Culture Collection, Rockville, MD), anti-Lyt-1.2 (C3PO.13) (15) (kindly provided by
Dr. Eli Sercarz, University of California at Los Angeles), and anti-Lyt-2 (3 .155) (16) (TIB
211, ATCC). The cells were then incubated with absorbed guinea pig complement at 37°C
for 40 min. 5-7-wk-old females were irradiated (1,000 rad from a "'Cesium source, Gam-
macell 40, Atomic Energy of Canada, Ltd., Ottawa, Ontario) and injected intravenously with
10-20 x 106 bone marrow cells. Chimeras are designated as bone marrow donor-irradi-
ated recipient. For example, an irradiated F, recipient that has received NOD bone marrow
is represented as NOD-Fl .
After a period of at least 2 mo, representative chimeras from each group were tested for
their extent of chimerism. Spleen cells from chimeras were typed with class I- and class II-
specific antibodies: anti-Kb.q, Dd, H-2' (34-4-20S) (17) (Litton Bionetics, Charleston, SC),
anti-Kd (2 .7.2) (18) (kindly provided by Dr. Terry Potter, Albert Einstein College of Medi-
cine, Bronx, NY), anti-I-Ab.d, H-2v.9 (34-5-3S) (17) (Litton Bionetics, Charleston, SC), which
is not reactive with the NOD I-A product, and anti-I-Ak,`,r,s," (10-2 .16) (19) (TIB 93, Amer-
ican Type Culture Collection), which is reactive with the NOD I-A product but not the B10
I-A product. The cells were incubated with 34-5-3S, 10-2 .16, or 34-4-20S for 30 min, washed,
and then incubated with FITC-conjugated goat anti-mouse IgG (Kirkegaard & Perry Labora-
tories, Inc., Gaithersburg, MD) that had been absorbed with a sepharose-conjugated mouse
IgM protein, MOPC 104E (Litton Bionetics). Cells incubated with 2 .7.2 were washed and
then incubated with FITC-conjugated monoclonal anti-rat x chain (MAR 18.5, Becton Dick-
inson & Co., Mountain View, CA). Cells were analyzed by flow cytometry on the FAGS IV
(Becton Dickinson & Co.).
Normal and chimeric mice were monitored for the development of diabetes by testing for
urinary glucose with TesTape (Eli Lilly, Indianapolis, IN). Animals were classified as dia-
betic after producing consistent TesTape values of 1+ or higher. To allow sufficient time for
the development of insulitis and/or diabetes, normal animals were killed at 7 mo old or older,
and chimeras were killed no sooner than 7 mo after construction. Some chimeras were al-
lowed to reach the age of 17 mo post-construction.
Neonatal Pancreas Transplantation.
￿
Selected NOD-F, chimeras received transplants of pan-
creata (20) obtained from NOD and B10 mice that were <24 h old. Each host received three
pancreata from newborn NOD mice under one renal capsule and three pancreata from new-
born B10 mice under the other renal capsule.
Histology.
￿
Pancreata were excised and fixed in buffered 10% formalin and processed for
paraffin sectioning. Tissue sections (5 gm) were stained with hematoxylin and eosin and
microscopically evaluated for the presence ofmononuclear cell infiltration. Histological spec-
imens were interpreted without knowledge of the treatment. Three noncontiguous sections
of each pancreas (45-50 gm between sections) were examined. Animals received a positive
score for insulitis ifinfiltrating mononuclear cells were observed within islets. Frozen sections
of pancreata were prepared for immunohistochemical staining of the L3T4 and Lyt-2 T cell
subsets. Ascites fluid containing anti-L3T4 antibodies (GK1 .5) (21) was prepared as previ-
ously described (9) and anti-Lyt-2 antibodies were obtained from Becton Dickinson & Co.
Sections were developed using the Vectastain ABC kit specific for rat IgG (Vector Laborato-
ries, Inc., Burlingame, CA) .WICKER ET AL .
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4-5 wk after transplantation, chimeras that received pancreas grafts were killed, and the
grafts were fixed in buffered 10 0 1c formalin and embedded in paraffin . Specimens were sec-
tioned (5-um thickness) and stained with hematoxylin and eosin to assess lymphocytic infiltra-
tion . Pancreatic beta cells within grafted tissue were identified with anti-insulin antibodies
in an indirect peroxidase anti-peroxidase method (DAKOPAP Kit, Accurate Chemical, West-
bury, NY) .
Results
Experimental Protocol .
￿
TheNODmouse develops insulitis by 3 mo ofage and nearly
70% of female NOD mice become diabetic between 3 and 7 mo of age (1) . In con-
trast, B10 mice do not display insulitis or develop diabetes . The expression of insu-
litis and diabetes is recessive since (NOD x B10)Fi mice do not become diabetic
or develop insulitis (12) . To ask whether the failure of(NOD x B10)Ft mice to ex-
press insulitis and develop diabetes can be attributed to the immune system or whether
the Ft fails to express appropriate target tissues for the autoimmune response,
lethally irradiated Fl mice were reconstituted with NOD bone marrow. To demon-
strate that the experimental manipulations alone did not induce diabetes or insu-
litis, Ft mice were irradiated and reconstituted with bone marrow obtained from
B10 or F1 mice . To confirm that the manipulations also did not prevent the devel-
opment of diabetes, NOD-'NOD bone marrow chimeras were constructed .
Extent of Chimerism .
￿
2 mo after construction, two mice from each group of non-
syngeneic chimeras, NOD-F, (three groups constructed) and B10-Ft (one group
constructed), were analyzed for their extent ofChmerism . In addition, a majority
of the NOD-F, chimeras were also analyzed when they were killed (>7 mo post-
construction) . Fluorescence profiles from an MHC typing experiment of a repre-
sentative NOD-F, chimera are shown in Fig . 1 . Greater than 95% of the spleen
FIGURE 1 .
￿
Spleen cells from (A)(NOD x B10)Fl, (B)NOD, and (C)
NOD-F, mice were tested for the presence of the Kb class I antigen
usingmAb 34-4-20S and anti-mouse IgG (FITC conjugate) as indi-
cated by the solid lines. The dashed lines represent cells incubated
with counterstain alone .1804
￿
BONE MARROW CELLS TRANSFER DIABETES AND INSULITIS
TABLE I
Prevalence of Diabetes and Insulitis in Normal and Chimeric Mice
Number with
insulitis/
￿
Number diabetic/
Strain
￿
total observed
￿
total observed
° Jo
NOD
￿
27/27 (100)
￿
72/108 (67)
(NOD x Bl0)F,
￿
0/54
￿
(0)
￿
0/100
￿
(0)
B10
￿
0/11 (0)
￿
0/100 (0)
NOD- NOD
￿
8/8 (100)
￿
8/8 (100)
NOD--,
￿
16/24 (67)
￿
5/24 (21)
B10-F,
￿
0/8 (0)
￿
0/15 (0)
Fl-F,
￿
0/6 (0)
￿
0/6 (0)
All mice represented in this table were females. Mice were evaluated at the onset of diabetes
or at >7 mo old or 7 mo after construction. Chimeras became diabetic between 2 and 10 mo
after construction. The average age of NOD mice at the onset of diabetes was 4 mo.
cells from all NOD-'F1 and B10-Ft chimeras tested expressed the class I and class
II MHC types of the bone marrow donor.
Expression ofInsulitisandDiabetes in Radiation BoneMarrow Chimeras.
￿
Results from
chimeras constructed to examine the influence of the experimental manipulations
on the development of insulitis and diabetes validated the use of this methodology
to study disease development. All NOD-NOD chimeras (n =8) became diabetic
3-7 mo after bone marrow transfer (Table I), and F1 -F1 and B10-F1 chimeras did
not become diabetic and did not display insulitis (Table I).
Insulitis was observed in 67% (n=24) of NOD-F t chimeras and five of these
mice (21%) developed diabetes within 9 mo after construction. From histologic ob-
servation, the insulitis seen in NOD-F1 chimeras did not appear to be different
from the spontaneous insulitis of NOD mice (Fig. 2 A). In addition, immuno-
histochemical analysis ofpancreatic inflammation demonstrated that islet infiltrates
were composed primarily of L3T4+ and Lyt-2+ lymphocytes (Fig. 2, B and C.
These same cell populations predominate in infiltrated NOD mouse islets (6, 8).
These data demonstrate that NOD bone marrow cells transfer the ability to mount
an autoimmune response to the pancreatic (3 cells present in normally nondiabetic
(NOD x B10)F1 mice.
Rejection ofNormal Islets byNOD-'Fl Chimeras.
￿
To demonstrate that normal pan-
creatic R cells can be the targets of the autoimmune process present in the NOD
mouse, pancreata from B10 and NOD newborn donors were transplanted under the
renal capsules of three diabetic and four nondiabetic NOD-F1 chimeras (Table II).
4-5 wk after transplantation, no insulin-containing p cells were observed in three
diabetic recipients (numbers 1-3) that had received B10 and NOD pancreas grafts.
Lymphocytic infiltration in the grafts ranged from mild to extensive. Both the NOD
and B10 Q cells were rejected in two nondiabetic recipients (numbers 4 and 5) as
evidenced by the lack of insulin-positive cells within the islets found in the grafted
pancreata. In a third nondiabetic recipient (number 6), the NOD R cells were re-
jected whereas insulin-positive cells within islets were observed in the B10 graft. Al-
though R cells were observed in the B10 graft in recipient number 6, a high levelWICKER ET AL .
FIGURE 2 .
￿
Histology of infiltrated islets of NOD-Fj chimeras . (A) Hematoxylin and eosin
staining showing insulitis (x 100) . Immunoperoxidase staining demonstrating (B) L3T4' and
(C) Lyt-2' cells within islet infiltrates (x200) .
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TABLE II
Transplantation of Pancreata from Newborn BI0 and NOD Mice to Diabetic
andNondiabetic NOD-FI Chimeras.
Pancreata from newborn B10 and NOD mice were grafted under the kidney capsules of NOD-F1 chimeras.
Recipients were killed 4-5 wk after transplantation. The host pancreas was examined histologically with
( + + + + ) massive insulitis and/or lack of intact islets consistent with overt diabetes and ( + + + ) the presence
of moderate to severe insulitis. Grafts were examined for the presence ( + ) or absence ( - ) of insulin-containing
p cells within defined islets . The level of lymphocytic infiltration within the grafts was scored as follows: ( + )
few infiltrating lymphocytes, ( + + ) moderate infiltration, and ( + + + ) intense infiltration .
of lymphocytic infiltration within the graft (score of + + +) suggests that this graft
would have been rejected at a later point in time. A fourth nondiabetic recipient
(number 7) failed to reject a cells in either graft since insulin-positive islets were
observed under both renalcapsules, and only mild to moderate lymphocytic infiltra-
tion was observed. As technical controls, syngeneic grafts of BALB/c pancreata to
BALB/c recipients and NOD and B10 pancreata to normal (NOD x B10)Fi
recipients showed very good islet structure, insulin-positive a cells within the islets,
and very few infiltrating lymphocytes (data not shown). In addition, we have previ-
ously shown that young NOD mice (5 wk old), which were free of insulitis at the
time of analysis, failed to reject the Q cells within pancreas transplants from new-
born donors (20) . Therefore, these data, showing that NOD-FI chimeras can re-
ject pancreatic beta cells from newborn B10 mice, indicate that the autoimmune
response in the NOD mouse is not specific for a R cell-associated antigen unique
to the NOD since R cells in the pancreata of normal B10 mice are also targets of
the autoimmune response.
Discussion
In the current report, we demonstrate that reconstitution of irradiated (NOD x
B10)F1 mice with NOD bone marrow cells causes insulitis in a majority of the
recipients and diabetes in some. The insulitis in NOD-"F1 chimeras is similar to
that observed in the NOD mouse since CD4 and CD8 T cells are observed within
the mononuclear cell infiltrates in both cases. In contrast, (NOD x B10)F1 mice
reconstituted with bone marrow cells from F t or 1310 mice did not display either
insulitis or diabetes. These data strongly suggest that the hematopoietic stem cells
of the NOD mouse contribute to the development of insulitis and diabetes and that
this genetically determined disease phenotype is not expressed by the hematopoietic
Recipient status
Recipient
pancreas p cells
Histology
NOD graft
Lymphocytic
infiltrates p cells
B10 graft
Lymphocytic
infiltrates
I . Diabetic + + + + - + - + + +
2 . Diabetic + + + + - + + - + +
3 . Diabetic + + + + - + + + - +
4. Nondiabetic + + + - + - + + +
5 . Nondiabetic + + + - + + - +
6. Nondiabetic + + + - + + + + + + +
7 . Nondiabetic + + + + + + + +WICKER ET AL.
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stem cells of (NOD x B10)F1 mice. The Fl mouse, however, does express appro-
priate target tissues for the initiation of the autoimmune process, since transfer of
hematopoietic stem cells from NOD mice results in insulitis and diabetes. In addi-
tion, we have demonstrated that the effector cells of the autoimmune destruction
in the NOD mouse can also recognize the pancreatic a cells from normal B10 mice.
Therefore, it is unlikely that an abnormal a cell is a primary cause of diabetes in
the NOD mouse. However, it is still possible that although normal islet tissue can
be the target ofthe autoimmune response, tissue present in normal mice may not
be able to initiate the autoimmune process. We are currently preparing a congenic
mouse strain, B10.H-210D, to address this issue. This strain will be histocompat-
ible with the NOD mouse and will express "normal" tissue (in contrast to the (NOD
x B10)F1, which could express a tissue-related diabetogenic phenotype inherited
from the NOD). If normal tissue is able to initiate the diabetogenic process in the
presence ofNOD bone marrow cells, then NOD-B10.H-2N°D chimeras should de-
velop insulitis and diabetes.
Therate ofonset ofdiabetes (2-10 mo after bone marrowreconstitution)observed
in both NOD-NOD and NOD-F1 chimeras is consistent with the observation
that normal NOD mice do not become diabetic before 3 mo ofage. Both in normal
mice and in radiation bone marrow chimeras, the maturation of lymphocytes and
the development of an autoimmune response must occur before the onset of dia-
betes. This relatively slow onset of disease contrasts with our previously reported
model for the adoptive transfer ofdiabetes (9). In this model, diabetes was induced
in 4-5-wk-old irradiated NOD mice 2-3 wk after receiving splenic T cells from dia-
betic donors. We demonstrated that both CD4 and CD8cells were required to transfer
diabetes and that both subsets had to be from "primed" (diabetic) donors.
Our observation that NOD-(NOD x B10)F1 chimeras can reject newborn B10
pancreas grafts is consistent with the findings ofTerada et al. (20) that suggest that
the effector cells ofthe autoimmune process in the NOD mouse are restricted by
class I gene products and that the target antigens ofthe autoimmune response are
found on the beta cells of normal mice. In the Terada et al. study, diabetic NOD
mice, which were treated with cyclosporin to prevent allograft rejection, received
transplants ofpancreata from newborn mice with various MHC haplotypes. C57BL/6
(which shares Db with NOD) and BALB/c (which shares K' with NOD) grafts were
both rejected, whereas CBA (which has a complete mismatch at the MHC with
NOD) grafts were accepted. Thus, the rejection ofnewborn B10 grafts by NOD-F1
chimeras observed in the current study could be mediated by effector cells restricted
by the class I product of the Db locus. The existence of class I-restricted effector
cells in the NOD mouse is also supported by the observation that Lyt-2+ T cells
(usually class I restricted), in addition to L3T4+ T cells (usually class II restricted),
are required to adoptively transfer diabetes in the NOD mouse (9, 10).
The observation that only 21% of NOD-Fl chimeras became diabetic as opposed
to the high incidence (100%) in NOD-NOD control chimeras suggests that the
full potential ofthe NOD bone marrow cells is not reached in the F1 environment.
We (12) and others (11, 13) have shown that the genetic control of diabetes in the
NOD mouse involves at least three functionally recessive genes, includingone linked
to the MHC. Thus, the most obvious distinction between F1- and NOD-irradiated
recipients is that both H-2NOD and H-26 class I and class II restriction elements are1808
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expressed on all appropriate nonhematopoietic tissues in NOD-F, chimeras,
whereas in NOD-NOD chimeras only H-2NOD restriction elements are expressed.
The presence of non-H-2'(" restriction elements on various cell types may con-
tribute to the less severe autoimmune response observed in NOD-F, chimeras. For
example, a lower density ofH-2NOD class I antigens on Q cells may make them less
susceptible to destruction by class I-restricted effector cells. Alternatively, in
NOD-;F, chimeras, radiation-resistant F, APC bearing both H-2b and H-2NOD
MHC antigens, which are present forvaryingperiods oftime after the construction
ofchimeras (22, 23), may not be as effective in inducing an autoimmune response
as APC that express only H-2NOD MHC antigens. There is also expression ofMHC
antigens from both haplotypes on thymic epithelial cells of NOD-}F, chimeras.
Thus, thymic learning would be altered and may cause the autoimmune response
to be less pronounced (less help, more suppression) in NOD-F, chimeras as com-
paredwith NOD-NOD chimeras. Studies with appropriate MHC congenic strains
will be needed to address these various alternatives.
In this study, we have demonstrated that thehematopoietic stem cellsofthe NOD
mouse contribute to the development ofdiabetes. The studies of Ikehara et al. (24)
also support this hypothesis since they demonstrated that NOD mice which were
lethally irradiated and reconstituted with allogeneic bone marrow cells did not de-
velop insulitisordiabetes. Further experimentstodefine how the diabetic genotype
ofthe NOD mouse is expressed via the immune system are clearly required. The
development ofcongenic strains separatingthe unlinked diabetogenicloci in the NOD
mousewill facilitate the discoveryofthe underlying mechanisms responsible forthe
development of diabetes.
Summary
The development ofautoimmune diabetes inthe nonobese diabetic(NOD) mouse
is controlled by at least three recessive loci, including one linked to the MHC. To
determine whetherany ofthesegeneticloci exert theireffectsviathe immune system,
radiation bone marrow chimeras were constructed in which (NOD x 1310)F,-
irradiated recipients were reconstituted with NOD bone marrow cells. Unmanipu-
lated (NOD x B10)F, mice, or irradiated F1 mice reconstituted with F, or B10 bone
marrow, did not display insulitis or diabetes. In contrast, insulitis was observed in
a majority of the NOD-"F, chimeras and diabetes developed in 21% of the mice.
These datademonstratethat expression ofthe diabeticphenotypein the NODmouse
is dependent on NOD-derived hematopoietic stem cells. Diabetogenic genes in the
NOD mouse do not appear to function at the level ofthe insulin-producing a cells
since NOD--, chimeras not only developed insulitis and diabetes but also rejected
a cells within pancreas transplants from newborn B10 mice. These data suggest that
the a cells of the NOD mouse do not express a unique antigenic determinant that
is the target of the autoimmune response.
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Note in added proof : Similar findings have been recently reported by Serreze et al. (25). They
demonstrated the transfer of diabetes to irradiated (NOD x NON)F1 hybrids with bone
marrow cells from NOD mice.
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